Progesterone Receptors in Mammary Gland Development and Tumorigenesis (original) (raw)

REFERENCES

1. R. D. Cardiff (2001). Validity of mouse mammary tumour models for human breast cancer: Comparative pathology. Microsc. Res. Tech. 52:224–230.
   PubMed Google Scholar
2. J. R. Harris, M. E. Lippman, U. Veronesi, and W. Willett (1992). Breast cancer (1). N. Engl. J. Med. 327:319–328.
   PubMed Google Scholar
3. B. E. Henderson, R K. Ross, and M. C. Pike (1991). Toward the primary prevention of cancer. Science 254:1131–1138.
   PubMed Google Scholar
4. J. L. Kelsey and M. D. Gammon (1991). The epidemiology of breast cancer. CA: Cancer J. Clin. 41:146–165.
   PubMed Google Scholar
5. L. A. Loeb (2001). Amutator phenotype in cancer. Cancer Res. 61:3230–3239.
   PubMed Google Scholar
6. D. V. Spicer, E. A. Krecker, and M. C. Pike (1995). The endocrine prevention of breast cancer. Cancer Invest. 13:495–504.
   PubMed Google Scholar
7. S. P. Robinson and V. C. Jordan (1987). Reversal of antitumor effects of tamoxifen by progesterone in the 7, 12-dimethylbenzanthracene-induced rat mammary carcinoma model. Cancer Res. 47:5386–5390.
   PubMed Google Scholar
8. H. Nagasawa, M. Aoki, N. Sakagami, and M. Ishida (1988). Medroxyprogesterone acetate enhances spontaneous mammary tumorigenesis and uterine adenomyosis in mice. Breast Cancer Res. Treat. 12:59–66.
   PubMed Google Scholar
9. B. S. McEwen (1991). Non-genomic and genomic effects of steroids on neural activity. Trends Pharmacol. Sci. 12:141–147.
   PubMed Google Scholar
10. C. Schairer, J. Lubin, R. Troisi, S. Sturgeon, L. Brinton, and R. Hoover (2000). Estrogen-progestin replacement and risk of breast cancer. JAMA 284:691–694.
    Google Scholar
11. L. Sivaraman and D. Medina (2002). Hormone-induced protection against breast cancer. J. Mammary Gland Biol. Neoplasia 7:77–92.
    PubMed Google Scholar
12. D. Medina, L. Sivaraman, S. G. Hilsenbeck, O. Conneely, M. Ginger, J. Rosen, et al. (2001). Mechanisms of hormonal prevention of breast cancer. Ann. N. Y. Acad. Sci. 952:23–35.
    PubMed Google Scholar
13. L. Sivaraman, O. M. Conneely, D. Medina, and B. W. O'Malley (2001). p53 is a potential mediator of pregnancy and hormoneinduced resistance to mammary carcinogenesis. Proc. Natl. Acad. Sci. U. S. A. 98:12379–12384.
    PubMed Google Scholar
14. S. M. Swanson, R. C. Guzman, G. Collins, P. Tafoya, G. Thordarson, F. Talamantes, et al. (1995). Refractoriness to mammary carcinogenesis in the parous mouse is reversible by hormonal stimulation induced by pituitary isografts. Cancer Lett. 90:171–181.
    PubMed Google Scholar
15. S. A. Onate, S. Y. Tsai, M. J. Tsai, and B. W. O'Malley (1995). Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270:1354–1357.
    PubMed Google Scholar
16. H. Gronemeyer (1991). Transcription activation by estrogen and progesterone receptors. Annu. Rev. Genet. 25:89–123.
    PubMed Google Scholar
17. Y. Kamei, L. Xu, T. Heinzel, J. Torchia, R. Kurokawa, B. Gloss, et al. (1996). A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85:403–414.
    PubMed Google Scholar
18. S. Y. Tsai, J. Carlsedt-Duke, N. L. Weigel, K. Dahlman, J. A. Gustafsson, M. J. Tsai, et al. (1988). Molecular interactions of steroid hormone receptor with its enhancer element: Evidence for receptor dimer formation. Cell 55:361–369.
    PubMed Google Scholar
19. G. F. Allan, X. H. Leng, S. Y. Tsai, N. L. Weigel, D. P. Edwards, M.-J. Tsai, et al. (1992). Hormone and antihormone induce distinct conformational changes which are central to steroid receptor activation. J. Biol. Chem. 267:19513–19520.
    PubMed Google Scholar
20. M. E. Meyer, C. Quirin-Stricker, T. Lerouge, M. T. Bocquel, and H. Gronemeyer (1992). A limiting factor mediates the differential activation of promoters by the human progesterone receptor isoforms. J. Biol. Chem. 267:10882–10887.
    PubMed Google Scholar
21. C. A. Sartorius, M. Y. Melville, A. R. Hovland, L. Tung, G. S. Takimoto, and K. B. Horwitz (1994). A third transactivation function (AF3) of human progesterone receptors located in the unique N-terminal segment of the B-isoform. Mol. Endocrinol. 8:1347–1360.
    PubMed Google Scholar
22. P. H. Giangrande, E. A. Kimbrel, D. P. Edwards, and D. P. McDonnell (2000). The opposing transcriptional activities of the two isoforms of the human progesterone receptor are due to differential cofactor binding. Mol. Cell. Biol. 20:3102–3115.
    PubMed Google Scholar
23. L. Tora, H. Gronemeyer, B. Turcotte, M. P. Gaub, and P. Chambon (1988). The N-terminal region of the chicken progesterone receptor specifies target gene activation. Nature 333:185–188.
    PubMed Google Scholar
24. E. Vegeto, M. M. Shahbaz, D. X. Wen, M. E. Goldman, B. W. O'Malley, and D. P. McDonnell (1993). Human progesterone receptor A form is a cell and promoter specific repressor of human progesterone receptor B function. Mol. Endocrinol. 7:1244–1255.
    PubMed Google Scholar
25. M. Breckwoldt, C. Keck, and U. Karack (1995). Benefits and risks of hormone replacement therapy (HRT). J. Steroid Biochem. Mol. Biol. 53:205–208.
    PubMed Google Scholar
26. A. R. Hovland, R. L. Powell, G. S. Takimoto, L. Tung, and K. B. Horwitz (1998). An N-terminal inhibitory function, IF, suppresses transcription by the A-isoform but not the B-isoform of human progesterone receptors. J. Biol. Chem. 273:5455–5460.
    PubMed Google Scholar
27. E. M. McGowan and C. L. Clarke (1999). Effect of overexpression of progesterone receptor A on endogenous progestinsensitive endpoints in breast cancer cells. Mol. Endocrinol. 13:1657–1671.
    PubMed Google Scholar
28. J. K. Richer, B. M. Jacobsen, N. G. Manning, M. G. Abel, D. M. Wolf, and K. B. Horwitz (2002). Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells. J. Biol. Chem. 277:5209–5218.
    PubMed Google Scholar
29. P. A. Mote, R. L. Balleine, E. M. McGowan, and C. L. Clarke (1999). Colocalization of progesterone receptors A and B by dual immunofluorescent histochemistry in human endometrium during the menstrual cycle. J. Clin. Endocrinol. Metab. 84:2963–2971.
    PubMed Google Scholar
30. R. L. Arnett-Mansfield, A. deFazio, G. V. Wain, R. C. Jaworski, K. Byth, P. A. Mote, et al. (2001). Relative expression of progesterone receptors A and B in endometrioid cancers of the endometrium. Cancer Res. 61:4576–4582.
    PubMed Google Scholar
31. R. K. Mangal, R. D. Wiehle, A. N. Poindexter, 3rd, and N. L. Weigel (1997). Differential expression of uterine progesterone receptor forms A and B during the menstrual cycle. J. Steroid Biochem. Mol. Biol. 63:195–202.
    PubMed Google Scholar
32. P A. Mote, R. L. Balleine, E. M. McGowan, and C. L. Clarke (2000). Heterogeneity of progesterone receptors A and B expression in human endometrial glands and stroma. Hum. Reprod. 15(Suppl. 3)48–56.
    PubMed Google Scholar
33. M. J. Tetel, P. H. Giangrande, S. A. Leonhardt, D. P. McDonnell, and D. P. Edwards (1999). Hormone-dependent interaction between the amino-and carboxyl-terminal domains of progesterone receptor in vitro and in vivo. Mol. Endocrinol. 13:910–924.
    PubMed Google Scholar
34. J. P. Lydon, F. J. DeMayo, C. R. Funk, S. K. Mani, A. R. Hughes, C. A. MontgomeryJr., et al. (1995). Mice lacking progesterone receptors exhibit pleiotropic reproductive abnormalities. Genes Dev. 9:2266–2278.
    PubMed Google Scholar
35. S. K. Mani, J. M. C. Allen, J. P. Lydon, B. Mulac-Jericevic, J. D. Blaustein, F. J. DeMayo, et al. (1996). Dopamine requires the unoccupied progesterone receptor to induce sexual behavior in mice. Mol. Endocrinol. 10:1728–1737.
    PubMed Google Scholar
36. P. E. Chappell, J. P. Lydon, O. M. Conneely, B. W. O'Malley, and J. E. Levine (1997). Endocrine defects in mice carrying a null mutation for the progesterone receptor gene. Endocrinology 138:4147–4152.
    PubMed Google Scholar
37. P. Chappell, J. S. Schneider, P. Kim, M. Xu, J. P. Lydon, B. W. O'Malley, et al. (1999). Absence of gonadotropin surges and gonadotropin-releasing hormone self-priming in ovariectomized (ovx), estrogen (E2)-treated, progesterone receptor knockout (PRKO) mice. Endocrinology 140:3653–3658.
    PubMed Google Scholar
38. O. M. Conneely, D. M. Kettelberger, M.-J. Tsai, W. T. Schrader, and B. W. O'Malley (1989). The chicken progesterone receptor A and B isoforms are products of an alternate translation initiation event. J. Biol. Chem. 264:14062–14064.
    PubMed Google Scholar
39. P. Kastner, A. Krust, B. Turcotte, U. Strupp, L. Tora, H. Gronemeyer, et al. (1990). Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. EMBO. J. 9:1603–1614.
    PubMed Google Scholar
40. P. H. Giangrande, G. Pollio, and D. P. McDonnell (1997). Mapping and characterization of the functional domains responsible for the differential activity of the A and B isoforms of the human progesterone receptor. J. Biol. Chem. 272:32889–32900.
    PubMed Google Scholar
41. B. Mulac-Jericevic, R. A. Mullinax, F. J. DeMayo, J. P. Lydon, and O. M. Conneely (2000). Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform. Science 289:1751–1754.
    PubMed Google Scholar
42. C. Brisken, S. Park, T. Vass, J. P. Lydon, B. W. O'Malley, and R. A. Weinberg (1998). A paracrine role for the epithelial progesterone receptor inmammarygland development. Proc. Natl. Acad. Sci. U. S. A. 95:5076–5081.
    PubMed Google Scholar
43. T. N. Seagroves, J. P. Lydon, R. C. Hovey, B. K. Vonderhaar, and J. M. Rosen (2000). C/EBPb(CCAAT/Enhancer Binding Protein) controls cell fate determination during mammary gland development. Mol. Endocrinol. 14:359–368.
    PubMed Google Scholar
44. L. Sivaraman, S. G. Hilsenbeck, L. Zhong, J. Gay, O. M. Conneely, D. Medina, et al. (2001). Early exposure of the rat mammary gland to estrogen and progesterone blocks colocalization of estrogen receptor expression and proliferation. J. Endocrinol. 171:75–83.
    PubMed Google Scholar
45. P. M. Ismail, J. Li, F. J. DeMayo, B. W. O'Malley, and J. P. Lydon (2002). A novel LacZ reporter mouse reveals complex regulation of the progesterone receptor promoter during mammary gland development. Mol. Endocrinol. 16:2475–2489.
    PubMed Google Scholar
46. S. L. Grimm, T. N. Seagroves, E. B. Kabotyanski, R. C. Hovey, B. K. Vonderhaar, J. P. Lydon, et al. (2002). Disruption of steroid and prolactin receptor patterning in the mammary gland correlates with a block in lobuloalveolar development. Mol. Endocrinol. 16:2675–2691.
    PubMed Google Scholar
47. R. B. Clarke, A. Howell, C. S. Potten, and E. Anderson (1997). Dissociation between steroid receptor expression and cell proliferation in the human breast. Cancer Res. 57:4987–4991.
    PubMed Google Scholar
48. C. Brisken, A. Heineman, T. Chavarria, B. Elenbaas, J. Tan, S. K. Dey, et al. (2000). Essential function of Wnt-4 in mammarygland development downstream of progesterone signaling. Genes Dev. 14:650–654.
    PubMed Google Scholar
49. P. A. Kelly, A. Bachelot, C. Kedzia, L. Hennighausen, C. J. Ormandy, J. J. Kopchick, et al. (2002). The role of prolactin and growth hormone in mammary gland development. Mol. Cell. Endocrinol. 197:127–131.
    PubMed Google Scholar
50. C. Brisken, A. Ayyannan, C. Nguyen, A. Heineman, F. Reinhardt, T. Jan, et al. (2002). IGF-2 is a mediator of prolactininduced morphogenesis in the breast. Dev. Cell 3:877–887.
    PubMed Google Scholar
51. P. Sicinski, J. L. Donaher, S. B. Parker, T. Li, A, Fazeli, H. Gardner, et al. (1995). Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 82:621–630.
    PubMed Google Scholar
52. W. P. Bocchinfuso and K. S. Korach (1997). Mammary gland development and tumorigenesis in estrogen receptor knockout mice. J. Mam. Gland Biol. Neoplasia 2:323–334.
    Google Scholar
53. V. Fantl, P. A. W. Edwards, J. H. Steel, B. K. Vonderhaar, and C. Dickson (1999). Impaired mammary gland development in cyl-1-/-mice during pregnancy and lactation is epithelial cell autonomous. Dev. Biol. 212:1–11.
    PubMed Google Scholar
54. G. Shyamala, X. Yang, G. Silberstein, M. H. Barcellos-Hoff, and E. Dale (1998). Transgenic mice carrying an imbalance in the native-ratio of A to B forms of progesterone receptor exhibit developmental abnormalities in mammary glands. Proc. Natl. Acad. Sci. U. S. A. 95:696–701.
    PubMed Google Scholar
55. G. B. Silberstein, K. Van Horn, G. Shyamala, and C. W. Daniel (1996). Progesterone receptors in the mouse mammary duct: Distribution and developmental regulation. Cell Growth Differ. 7:945–952.
    PubMed Google Scholar
56. J. P. Lydon, G. Ge, F. S. Kittrell, D. Medina, and B. W. O'Malley (1999). Murine mammary gland carcinogenesis is critically dependent on progesterone receptor function. Cancer Res. 59:4276–4284.
    PubMed Google Scholar
57. S. Soyal, P. M. Ismail, J. Li, B. Mulac-Jericevic, O. M. Conneely, and J. P. Lydon (2002). Progesterone's role in mammary gland development and tumorigenesis as disclosed by experimental mouse genetics. Breast Cancer Res. 4:191–196.
    PubMed Google Scholar
58. R. T. Chatterton, Jr., J. P. Lydon, R. G. Mehta, E. T. Mateo, A. Pletz, and V. C. Jordan (2002). Role of the progesterone receptor (PR) in susceptibility of mouse mammary gland to 7, 12-dimethylbenz[a]anthracene-induced hormoneindependent preneoplastic lesions in vitro. Cancer Lett. 188:47–52.
    PubMed Google Scholar
59. R. K. Ross, A. Paganini-Hill, P. C. Wan, and M. C. Pike (2000). Effect of hormone replacement therapy on breast cancer risk: Estrogen versus estrogen plus progestin. J. Natl. Cancer Inst. 92:328–332.
    PubMed Google Scholar
60. R. Sitruk-Ware (2002). Progestogens in hormal replacement therapy: New molecules, risks, and benefits. Menopause: J. North Am. Menopause Soc. 9:6–15.
    Google Scholar
61. P. A. Mote, S. Bartow, N. Tran, and C. L. Clarke (2002). Loss of co-ordinate expression of progesterone receptors A and B is an early event in breast carcinogenesis. Breast Cancer Res. Treat. 72:163–172.
    PubMed Google Scholar
62. J. D. Graham, C. Yeates, R. L. Balleine, S. S. Harvey, J. S. Milliken, A. M. Bilous, et al. (1995). Characterization of progesterone receptor A and B expression in human breast cancer. Cancer Res. 55:5063–5068.
    PubMed Google Scholar
63. G. Shyamala, X. Yang, R. D. Cardiff, and E. Dale (2000). Impact of progesterone receptor on cell-fate decisions during mammary gland development. Proc. Natl. Acad. Sci. U. S. A. 97:3044–3049.
    PubMed Google Scholar
64. E. C. Hirsch, M. G. A. and Y. Agid (1989). Selective vulnerability of pigmented dopaminergic neurons in Parkinson's disease. Acta Neurol. Scand. Suppl. 126:19–22.
    PubMed Google Scholar
65. E. Marshal (1993). Search for a killer: Focus shifts from fat to hormones. Science 259:618–621.
    PubMed Google Scholar
66. K. U. Wagner, C. A. Boulanger, M. D. Henry, M. Sgagias, L. Hennighausen, and G. H. Smith (2002). An adjunct mammary epithelial cell population in parous females: Its role in functional adaptation and tissue renewal. Development 129:1377–1386.
    PubMed Google Scholar
67. M. R. Ginger, M. F. Gonzalez-Rimbau, J. P. Gay, and J. M. Rosen (2001). Persistent changes in gene expression induced by estrogen and progesterone in the rat mammary gland. Mol. Endocrinol. 15:1993–2009.
    PubMed Google Scholar
68. C. M. D'Cruz, S. E. Moody, S. R. Master, J. L. Hartman, E. A. Keiper, M. B. Imielinski, et al. (2002). Persistent parity-induced changes in growth factors, TGF-beta3, and differentiation in the rodent mammary gland. Mol. Endocrinol. 16:2034–2051.
    PubMed Google Scholar

Download references